Aim: The clinicopathological effects of Bmi-1 expression in esophageal cancer remain widely disputed. Our aim was to clarify this relationship.
Methods: Available studies were retrieved from diverse databases. Review Manager 5.3 and Stata 12.0 software were used to identify correlations between Bmi-1 expression and the clinicopathological features of esophageal cancer.
Results: From 16 studies, 1523 esophageal cancer patients were analyzed. Meta-analysis demonstrated that Bmi-1 overexpression was associated with differentiation (p = 0.03), tumor/node/metastasis stage (p = 0.02), depth of invasion (p = 0.0006) and lymph node metastasis (p = 0.008).
Conclusion: The expression of Bmi-1 is associated with the progression and invasion of esophageal cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2217/bmm-2017-0092 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!